Tirzepatide on obstructive sleep apnea-related cardiometabolic risk: secondary outcomes of the SURMOUNT-OSA randomized trial. (nature.com)

Authors: Malhotra A … Bednarik J Journal: Nature Medicine Published: 2026-02-01 DOI: https://doi.org/10.1038/s41591-025-04071-1